Soligenix, Inc.
corporate_fare Company Profile
Soligenix, Inc. (NASDAQ:SNGX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for SNGX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for SNGX spans 10-Q, 8-K, 424B3, PRER14A.
Recent high-impact activity:
- Soligenix Q3 2026: Cash Up to $9.0M, Net Loss Narrows, Going Concern Persists
- Soligenix Stockholders Approve Reverse Split and 67% Increase in Authorized Shares
- Soligenix Registers 5.3M Warrant Shares as Going Concern and Nasdaq Delisting Risks Mount
- Soligenix Q2 2026: Going Concern Warning, Nasdaq Delisting Risk, and Heavy ATM Dilution
- Soligenix Q2 10-Q Flags Going Concern, Nasdaq Delisting Risk, and Heavy ATM Dilution
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 66,373 shares in SNGX as of the October 30, 2026 settlement, a 59.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 20.8% of SNGX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for SNGX, detected from its recent SEC filings · based on capital-structure filings through 2026-11-06.
Going Concern Warning · Nasdaq Delisting Risk
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →